MIRA INFORM REPORT

 

 

Report Date :

07.02.2013

 

IDENTIFICATION DETAILS

 

Name :

NGANGPA PHARMACY & MEDICAL EQUIPMENTS

 

 

Registered Office :

Post Box no. 1664 Norzin lam, Thimphu

 

 

Country :

Bhutan

 

 

Date of Incorporation :

15.05.2008

 

 

Legal Form :

Partnership

 

 

Line of Business :

Distributors of Medical Equipment and Medicine.

 

 

No. of Employees :

12

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

 


NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2011)

Current Rating

(30.06.2012)

Bhutan

B2

B2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

BHUTAN - ECONOMIC OVERVIEW

 

The economy, one of the world's smallest and least developed, is based on agriculture and forestry, which provide the main livelihood for more than 40% of the population. Agriculture consists largely of subsistence farming and animal husbandry. Rugged mountains dominate the terrain and make the building of roads and other infrastructure difficult and expensive. The economy is closely aligned with India's through strong trade and monetary links and is dependent on India's financial assistance. The industrial sector is technologically backward with most production of the cottage industry type. Most development projects, such as road construction, rely on Indian migrant labor. Model education, social, and environment programs are underway with support from multilateral development organizations. Each economic program takes into account the government's desire to protect the country's environment and cultural traditions. For example, the government, in its cautious expansion of the tourist sector, encourages visits by upscale, environmentally conscientious tourists. Complicated controls and uncertain policies in areas such as industrial licensing, trade, labor, and finance continue to hamper foreign investment. The import of equipment and fuel to build hydropower plants is leading to large trade and current account deficits, though new hydropower projects and electricity exports to India are creating employment and will probably sustain growth in the coming years. GDP has rebounded strongly since the global recession began in 2008.

Source : CIA


Company name and address 

 

 

 

 

 

 

Ngangpa Pharmacy & Medical Equipments

Post Box no. 1664

Norzin lam, Thimphu, Bhutan

 

Tel:       +975-02-336439/77208327/17116454

Fax:      +975-02-336439/334081

E-mail: Drsingey2000@yahoo.com

ngangpapharmacy@yahoo.com

 

 

summary

 

Year Established                                   :           15.05.2008

 

Legal Status                                          :           Partnership

 

Name of Partners                                   :           1. Ngangpa Lama.

                                                                        2. Urgen Lama.

 

 

Auditors                                                :           S.K. Chettri  & Co. Thimpu, Bhutan

 

Staff                                                      :           12 nos.

                                               

Bankers                                                :           Bank of Bhutan

                                                                        Thimpu, Bhutan

                                                                       

Office Space                                          :           1000 sq.ft. (Leasehold)

 

Activities                                               :           Distributors of Medical Equipment and Medicine.

 

Business                                               :          

In order to address issues of delay, erratic supplies and various other problems the cabinet during its recent meeting discussed the rental reagent system and proposals were invited from all the registered suppliers.

A total of three local suppliers/companies submitted proposals. The companies are M/s Ngangpa Pharmacy & Medical Equipment, M/s Ugen Medical Stores and M/s Dzambala Suppliers. After evaluation of proposals based on technical and financial aspects, M/s Ngangpa Pharmacy& Medical Equipment was selected.

A cabinet news release stated that the cost benefit analysis indicate a total saving of Nu 6.18mn per year. In addition to cost savings, the other benefits that can be accrued by introducing the reagent rental system are that of uninterrupted laboratory services due to back-up system and less downtime, savings from not buying the equipment (Approximately Nu 3-5mn).

The introduction of the reagent will also help savings from administrative burden due to tendering formalities while it will improve overall quality of laboratory services through strengthening of IQC System, establishment of NEQAS and accreditation of laboratory services.

The contract will be signed with the selected supplier for 5-6 years and this system will be expanded to other Sections of Laboratory Services and Regional Referral Hospitals in the future.

The health ministry (MoH) is in the process to introduce reagent rental system in the Biochemistry Section under Department of Laboratory Medicine at the Thimphu national referral hospital (JDWNRH).

Under this system, the equipment (Bio-chemistry Analyzer) will be provided free of cost by the company with the condition that the MoH purchase reagents from the same company for a certain contract period. During the period, the equipment will be maintained by the same company.

Under current practices, the MoH procures the laboratory equipment and consumables (reagents, machine parts and accessories) and distributes to the Hospitals. However, this practice is inconvenient for many reasons.

The Long procurement procedures and default by suppliers often lead to erratic supply of laboratory reagents. Secondly, competitive bidding system often results in the selection of multi-brand reagents and equipment (as the selection is based on the lowest evaluated Bids), which makes the implementation of quality assurance system difficult.

Due to difficulty in getting spare parts and availability of limited skills in maintenance, repair, calibration setting, etc. results in interruption and poor quality of laboratory services and lack of proper standardization has resulted in poor quality of laboratory services.

The current practice also gave rise to total dependence on outside vendors due to lack of manufacturing facility and limited technical know-how within the country. Even with signing of annual maintenance contract, the response from the suppliers is still not satisfactory.

Add to that, high maintenance costs are incurred for maintenance and repair of equipment while high capital investment is required to purchase laboratory equipment and reagents.

 

 

 

 

 

 

Reference of Overseas Concerns             :           USA, Germany.                                                            

 

Finance                                                             :           Present Working Capital – Nu.6.00 crores.

 

                                                                        Sales (2011)                              :           Nu. 7  crores.                                                                                        Sales (2012)                              :           Nu. 8  crores.

                                                                        Projected Sales (2013)               :           Nu.10  crores.

 

Trading Terms                                                    :Purchase         -           L/C – 30 days

                                                                                                            Credit – 30 days

 

                                                                        Sales                -           L/C – 30 days

                                                                                                            Credit – 30 days

                                   

Remarks                                                           :Partners are well experienced and active.  Payments are

                                                                        Reported to be correct and regular as per commitment.

                                                                        Trade relations are fair. Business may be done USD 5000000 on TPDA 90 days.

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.53.08

UK Pound

1

Rs.83.12

Euro

1

Rs.72.02

 

 

INFORMATION DETAILS

 

Report Prepared by :

PRL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.